Joshua De Leon

1.5k total citations · 1 hit paper
42 papers, 1.0k citations indexed

About

Joshua De Leon is a scholar working on Physiology, Surgery and Molecular Biology. According to data from OpenAlex, Joshua De Leon has authored 42 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 8 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Joshua De Leon's work include Systemic Lupus Erythematosus Research (6 papers), Alzheimer's disease research and treatments (6 papers) and Lipoproteins and Cardiovascular Health (4 papers). Joshua De Leon is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Alzheimer's disease research and treatments (6 papers) and Lipoproteins and Cardiovascular Health (4 papers). Joshua De Leon collaborates with scholars based in United States. Joshua De Leon's co-authors include Allison B. Reiss, Lora J. Kasselman, Iryna Voloshyna, Saba Ahmed, Nobuyuki Miyawaki, Amy D. Glass, Nicolle Siegart, Aaron Pinkhasov, Joseph Mattana and Mark M. Stecker and has published in prestigious journals such as Nutrients, International Journal of Environmental Research and Public Health and American Heart Journal.

In The Last Decade

Joshua De Leon

36 papers receiving 988 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target

2021 158 citations Saba Ahmed, Lora J. Kasselman et al. Metabolites profile →

Peers

Countries citing papers authored by Joshua De Leon

Since Specialization

Citations

This map shows the geographic impact of Joshua De Leon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua De Leon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua De Leon more than expected).

Fields of papers citing papers by Joshua De Leon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua De Leon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua De Leon. The network helps show where Joshua De Leon may publish in the future.

Co-authorship network of co-authors of Joshua De Leon

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua De Leon. A scholar is included among the top collaborators of Joshua De Leon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua De Leon. Joshua De Leon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss 2025 ·Biomolecules ·Allison B. Reiss, (unknown), (unknown), (unknown), (unknown), Heather A. Renna, Joshua De Leon	13
2	Role of Apolipoprotein E in Alzheimer's Disease Pathogenesis, Prognosis and Treatment 2024 ·Discovery Medicine ·Allison B. Reiss, (unknown), (unknown), (unknown), (unknown), (unknown), Aaron Pinkhasov, Irving H. Gomolin, Thomas Wısnıewskı, Joshua De Leon	3
3	An Assessment of the Ocular Toxicity of Two Major Sources of Environmental Exposure 2024 ·International Journal of Environmental Research and Public Health ·(unknown), Lora J. Kasselman, Ankita Srivastava, Joshua De Leon, Allison B. Reiss	0
4	Mitochondria in Alzheimer’s Disease Pathogenesis 2024 ·Life ·Allison B. Reiss, (unknown), (unknown), (unknown), Aaron Pinkhasov, Irving H. Gomolin, Mark M. Stecker, Thomas Wısnıewskı, Joshua De Leon	36
5	Nilotinib as a Prospective Treatment for Alzheimer’s Disease: Effect on Proteins Involved in Neurodegeneration and Neuronal Homeostasis 2024 ·Life ·Ankita Srivastava, Heather A. Renna, (unknown), Katie Jane Sheehan, Saba Ahmed, Thomas Palaia, Aaron Pinkhasov, Irving H. Gomolin, Thomas Wısnıewskı, Joshua De Leon, Allison B. Reiss	0
6	The Effect of Androgen Deprivation Therapy on the Cardiovascular System in Advanced Prostate Cancer 2024 ·Medicina ·Allison B. Reiss, (unknown), (unknown), (unknown), (unknown), (unknown), Joshua De Leon, Aaron E. Katz	0
7	Cognitive Function and the Consumption of Probiotic Foods: A National Health and Nutrition Examination Survey Study 2024 ·Nutrients ·Lora J. Kasselman, Morgan R. Peltier, Joshua De Leon, Allison B. Reiss	1
8	Maximizing the Clinical Value of Blood-Based Biomarkers for Mild Traumatic Brain Injury 2023 ·Diagnostics ·(unknown), Aaron Pinkhasov, (unknown), Dimitris G. Placantonakis, Joshua De Leon, Allison B. Reiss	3
9	Toxic External Exposure Leading to Ocular Surface Injury 2023 ·Vision ·(unknown), (unknown), (unknown), Joshua De Leon, Morgan R. Peltier, Allison B. Reiss	16
10	Alzheimer’s Disease Treatment: The Search for a Breakthrough 2023 ·Medicina ·Allison B. Reiss, (unknown), (unknown), (unknown), Aaron Pinkhasov, Irving H. Gomolin, Mark M. Stecker, Thomas Wısnıewskı, Joshua De Leon	17
11	Androgen Deprivation Therapy for Prostate Cancer: Focus on Cognitive Function and Mood 2023 ·Medicina ·Allison B. Reiss, (unknown), Aaron Pinkhasov, (unknown), (unknown), Joshua De Leon, Aaron E. Katz	6
12	Long COVID, the Brain, Nerves, and Cognitive Function 2023 ·Neurology International ·Allison B. Reiss, C. E. Greene, (unknown), (unknown), Mark M. Stecker, Joshua De Leon, Aaron Pinkhasov	39
13	Therapeutic Potential of P110 Peptide: New Insights into Treatment of Alzheimer’s Disease 2023 ·Life ·Ankita Srivastava, (unknown), Heather A. Renna, (unknown), Saba Ahmed, Thomas Palaia, Aaron Pinkhasov, Irving H. Gomolin, Joshua De Leon, Allison B. Reiss	12
14	Exosomes in Cardiovascular Disease: From Mechanism to Therapeutic Target 2023 ·Metabolites ·Allison B. Reiss, Saba Ahmed, (unknown), (unknown), Joshua De Leon	33
15	Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse model 2022 ·Journal of Traditional and Complementary Medicine ·Lora J. Kasselman, Heather A. Renna, Iryna Voloshyna, Aaron Pinkhasov, Irving H. Gomolin, (unknown), Joshua De Leon, Steven E. Carsons, Allison B. Reiss	4
16	Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target breakdown → 2021 ·Metabolites ·(unknown), Saba Ahmed, (unknown), Lora J. Kasselman, Joshua De Leon, Amy D. Glass, Allison B. Reiss	158
17	The role of interferon-γ in cardiovascular disease: an update 2020 ·Inflammation Research ·(unknown), Iryna Voloshyna, Saba Ahmed, Lora J. Kasselman, (unknown), Joshua De Leon, Allison B. Reiss	55
18	Oxytocin: Potential to mitigate cardiovascular risk 2019 ·Peptides ·Allison B. Reiss, Daniel S. Glass, (unknown), Amy D. Glass, Joshua De Leon, Lora J. Kasselman	20
19	CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies 2018 ·Atherosclerosis ·Allison B. Reiss, Nobuyuki Miyawaki, (unknown), Lora J. Kasselman, Iryna Voloshyna, (unknown), Joshua De Leon	159
20	Interleukin-6 in atherosclerosis: atherogenic or atheroprotective? 2017 ·Clinical Lipidology ·Allison B. Reiss, Nicolle Siegart, Joshua De Leon	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact